EAM
TMO icon

Eagle Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

Eagle Asset Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-3,596
Closed -$1.88M – 566
2023
Q2 		$1.88M Sell
3,596
-3,349
-48% -$1.81M 0.01% 446
2023
Q1 		$4M Sell
6,945
-3,753
-35% -$2.12M 0.02% 370
2022
Q4 		$5.92M Sell
10,698
-2,655
-20% -$1.41M 0.04% 308
2022
Q3 		$6.77M Sell
13,353
-272
-2% -$152K 0.04% 295
2022
Q2 		$7.4M Sell
13,625
-500
-4% -$275K 0.05% 287
2022
Q1 		$8.34M Sell
14,125
-1,517
-10% -$871K 0.04% 304
2021
Q4 		$10.4M Buy
15,642
+406
+3% +$253K 0.05% 303
2021
Q3 		$8.7M Buy
15,236
+2,564
+20% +$1.41M 0.04% 339
2021
Q2 		$6.39M Sell
12,672
-8,274
-40% -$3.9M 0.03% 390
2021
Q1 		$9.56M Buy
20,946
+20,142
+2,505% +$9.61M 0.04% 325
2020
Q4 		$374K Sell
804
-19,613
-96% -$9.2M ﹤0.01% 480
2020
Q3 		$8.87M Buy
20,417
+4,720
+30% +$1.95M 0.05% 299
2020
Q2 		$5.51M Sell
15,697
-6,278
-29% -$2.1M 0.03% 363
2020
Q1 		$6.23M Buy
21,975
+68
+0.3% +$21.4K 0.04% 338
2019
Q4 		$7.12M Sell
21,907
-63
-0.3% -$19.1K 0.03% 357
2019
Q3 		$6.4M Sell
21,970
-128
-0.6% -$36.7K 0.03% 369
2019
Q2 		$6.49M Buy
22,098
+4,622
+26% +$1.27M 0.03% 374
2019
Q1 		$4.78M Buy
17,476
+224
+1% +$55.7K 0.03% 416
2018
Q4 		$3.86M Sell
17,252
-159
-0.9% -$37.3K 0.02% 421
2018
Q3 		$4.25M Buy
17,411
+498
+3% +$115K 0.02% 450
2018
Q2 		$3.5M Buy
16,913
+310
+2% +$65.8K 0.02% 464
2018
Q1 		$3.43M Buy
16,603
+79
+0.5% +$16.6K 0.02% 473
2017
Q4 		$3.43M Sell
16,524
-126
-0.8% -$24.1K 0.02% 478
2017
Q3 		$3.19M Sell
16,650
-127
-0.8% -$23K 0.02% 488
2017
Q2 		$2.93M Sell
16,777
-8
-0% -$1.34K 0.02% 493
2017
Q1 		$2.58M Buy
16,785
+425
+3% +$65K 0.02% 526
2016
Q4 		$2.31M Buy
+16,360
New +$2.41M 0.02% 534
2013
Q3 		– Sell
-36,494
Closed -$3.09M – 709
2013
Q2 		$3.09M Buy
+36,494
New +$3.04M 0.02% 546

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Eagle Asset Management's TMO Position: Q3 2023 in Review

Eagle Asset Management sold out of Thermo Fisher Scientific (TMO) in Q3 2023, closing a stake of 3,596 shares — an estimated $1.88M sold.

Eagle Asset Management first reported a position in TMO in Q2 2013 and held it in 28 quarters. The position peaked at $10.4M in Q4 2021. 2,365 funds tracked by Wall St. Rank hold TMO as of Q3 2023.

  • Eagle Asset Management reported no remaining Thermo Fisher Scientific position as of Q3 2023 after selling out during the quarter.
  • Eagle Asset Management sold 3,596 Thermo Fisher Scientific shares in Q3 2023, an estimated $1.88M.
  • Eagle Asset Management first reported a position in Thermo Fisher Scientific in Q2 2013 and held it in 28 quarters.
  • Eagle Asset Management's Thermo Fisher Scientific position peaked at $10.4M in Q4 2021.
  • 2,365 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2023.

Based on Eagle Asset Management's 13F filing for Q3 2023, filed 13 Nov 2023.